Results 221 to 230 of about 52,751,136 (335)

Pathways linking health literacy to diabetes risk scores in a non-diabetic population in Ismailia, Egypt: a cross sectional study design. [PDF]

BMC Public Health
Tawfik MY, Mohamed RA, Elsaid NMAB.
europepmc   +1 more source

FUNDAMENTAL STUDIES ON VIBRATION CHARACTERISTICS AND ASEISMIC DESIGN OF SUBMERGED BRIDGE PIERS

, 1963
Hisao Goto, Kenzo Toki
openalex   +2 more sources

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

Effects of a six-month yoga intervention on vascular parameters in sedentary office workers: An interrupted time-series study design. [PDF]

J Educ Health Promot
Paramashiva PS, Annapoorna K, Vaishali K, Shivashankar KN, Chandrasekaran B, Yerraguntla K, Reddy GG, Sukumar S, Ravichandran S, Shettigar D, Muthu SS, Kamath K, Biji C, Kadavigere R.   +13 more
europepmc   +1 more source

Improved coolant backup 100-B, D, F, DR, H and C areas design study

, 1960
M.H. Schack, W.J. Tupper
openalex   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Implementing a transmural model of early palliative care in advanced dementia: the use of a hybrid effectiveness-implementation study design. [PDF]

BMC Geriatr
Hum A, Kaur P, Goh WY, Tay R, Neo HY, Koh MYH, Ali NB, Lim WS, Tan YJ, Wu HY, Kannapiran P, Tan HTR, Sun Y, Ong CE, Sachdev RS, Low ZJ, Tey LH, Tan WS, Ding YY.   +18 more
europepmc   +1 more source

Coolant backup design study basis and objective

, 1960
M.H. Schack, W.J. Tupper
openalex   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

Cognitive and Neuroimaging for Neurodegenerative Disorders: A Cohort Study Design with Initial Findings

Hosseini AA, Shao B, Lee AR, Dhillon P, Junaid K, Gran B, Sellars P, Sargisson H, Jung J, Mukaetova-Ladinska E.   +9 more
europepmc   +1 more source